Mackay Shields LLC lowered its holdings in shares of Ceridian HCM Holding Inc. (NYSE:CDAY – Get Rating) by 1.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,348 shares of the company’s stock after selling 284 shares during the period. Mackay Shields LLC’s holdings in Ceridian HCM were worth $2,126,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the business. Capital Research Global Investors raised its stake in Ceridian HCM by 0.5% during the 3rd quarter. Capital Research Global Investors now owns 18,356,104 shares of the company’s stock valued at $2,067,270,000 after acquiring an additional 98,972 shares in the last quarter. Janus Henderson Group PLC raised its stake in shares of Ceridian HCM by 0.7% in the 3rd quarter. Janus Henderson Group PLC now owns 6,645,804 shares of the company’s stock worth $748,451,000 after buying an additional 47,989 shares in the last quarter. Artisan Partners Limited Partnership raised its stake in shares of Ceridian HCM by 26.0% in the 3rd quarter. Artisan Partners Limited Partnership now owns 3,321,754 shares of the company’s stock worth $374,096,000 after buying an additional 685,918 shares in the last quarter. Bamco Inc. NY raised its stake in shares of Ceridian HCM by 2.8% in the 3rd quarter. Bamco Inc. NY now owns 3,124,775 shares of the company’s stock worth $351,912,000 after buying an additional 84,656 shares in the last quarter. Finally, Wellington Management Group LLP raised its stake in shares of Ceridian HCM by 73.9% in the 3rd quarter. Wellington Management Group LLP now owns 2,396,160 shares of the company’s stock worth $269,854,000 after buying an additional 1,018,465 shares in the last quarter.
Shares of CDAY stock opened at $59.58 on Tuesday. The stock has a market cap of $9.06 billion, a P/E ratio of -119.16 and a beta of 1.47. Ceridian HCM Holding Inc. has a one year low of $58.32 and a one year high of $130.37. The stock has a fifty day moving average price of $67.56 and a 200 day moving average price of $92.05. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.11 and a quick ratio of 1.11.
A number of analysts have recently commented on the company. Credit Suisse Group assumed coverage on Ceridian HCM in a research note on Wednesday, March 23rd. They issued an “outperform” rating and a $85.00 price objective on the stock. Wells Fargo & Company dropped their target price on Ceridian HCM from $85.00 to $65.00 and set an “equal weight” rating on the stock in a report on Tuesday, March 15th. Wolfe Research downgraded Ceridian HCM from a “peer perform” rating to an “underperform” rating in a report on Friday, February 11th. BMO Capital Markets started coverage on Ceridian HCM in a report on Wednesday, February 2nd. They issued an “outperform” rating and a $91.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on Ceridian HCM from $110.00 to $105.00 and set a “buy” rating on the stock in a report on Thursday, February 10th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $98.55.
In other news, EVP Christopher R. Armstrong sold 3,891 shares of the firm’s stock in a transaction on Wednesday, February 9th. The stock was sold at an average price of $79.48, for a total value of $309,256.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jeffrey Scott Jacobs sold 784 shares of the firm’s stock in a transaction on Wednesday, March 9th. The shares were sold at an average price of $62.49, for a total value of $48,992.16. The disclosure for this sale can be found here. Insiders have sold 13,353 shares of company stock valued at $900,537 over the last quarter. Corporate insiders own 3.90% of the company’s stock.
About Ceridian HCM (Get Rating)
Ceridian HCM Holding Inc, together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market.
- Get a free copy of the StockNews.com research report on Ceridian HCM (CDAY)
- 3 No-Brainer Stocks to Buy with $1000
- Rite Aid Stock is Getting Cheap Enough to Buy Here
- Analysts Reel In Netflix Targets Ahead Of Q1 Earnings
- MarketBeat Podcast: Making Money in the Red-Hot Housing Market
- Banking On Bank Of America
Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.